[ Price : $8.95]
FDA warns Czechias Respilon Production about CGMP violations in its manufacturing of over-the-counter drugs.[ Price : $8.95]
A Bioprocess Online guest column outlines recent changes to FDAs accelerated approval pathway that were made to address systemic f...[ Price : $8.95]
TransCelerate reports on a 2025 tabletop exercise it convened with the CDER Center for Clinical Trial Innovation that focused on s...[ Price : $8.95]
New reporting reveals that FDA has withdrawn or blocked the publication of multiple internal studies supporting the safety of Covi...[ Price : $8.95]
FDA warns Orlando, FL-based Active Cosmetics Manufacturing about CGMP violations in its production of finished drugs.[ Price : $8.95]
The U.S. Supreme Court issues a temporary pause on a 5/1 lower court ruling that would have curtailed access to the abortion pill ...[ Price : $8.95]
An opinion article notes that recent FDA regulatory decisions are leading to a sharper focus on the evidentiary standards underpin...[ Price : $8.95]
FDA sends an untitled letter to Alnylam Pharmaceuticals, citing misleading promotional claims on a consumer-facing Web site for it...